228 related articles for article (PubMed ID: 35544594)
1. Dichotomous role of miR193b-3p in diabetic foot ulcers maintains inhibition of healing and suppression of tumor formation.
Marjanovic J; Ramirez HA; Jozic I; Stone RC; Wikramanayake TC; Head CR; Abdo Abujamra B; Ojeh N; Kirsner RS; Lev-Tov H; Pastar I; Tomic-Canic M
Sci Transl Med; 2022 May; 14(644):eabg8397. PubMed ID: 35544594
[TBL] [Abstract][Full Text] [Related]
2. Cellular reprogramming of diabetic foot ulcer fibroblasts triggers pro-healing miRNA-mediated epigenetic signature.
Pastar I; Marjanovic J; Liang L; Stone RC; Kashpur O; Jozic I; Head CR; Smith A; Gerami-Naini B; Garlick JA; Tomic-Canic M
Exp Dermatol; 2021 Aug; 30(8):1065-1072. PubMed ID: 34114688
[TBL] [Abstract][Full Text] [Related]
3. Topical mevastatin promotes wound healing by inhibiting the transcription factor c-Myc via the glucocorticoid receptor and the long non-coding RNA Gas5.
Sawaya AP; Pastar I; Stojadinovic O; Lazovic S; Davis SC; Gil J; Kirsner RS; Tomic-Canic M
J Biol Chem; 2018 Jan; 293(4):1439-1449. PubMed ID: 29158265
[TBL] [Abstract][Full Text] [Related]
4. Increased number of Langerhans cells in the epidermis of diabetic foot ulcers correlates with healing outcome.
Stojadinovic O; Yin N; Lehmann J; Pastar I; Kirsner RS; Tomic-Canic M
Immunol Res; 2013 Dec; 57(1-3):222-8. PubMed ID: 24277309
[TBL] [Abstract][Full Text] [Related]
5. Glucocorticoid-mediated induction of caveolin-1 disrupts cytoskeletal organization, inhibits cell migration and re-epithelialization of non-healing wounds.
Jozic I; Abujamra BA; Elliott MH; Wikramanayake TC; Marjanovic J; Stone RC; Head CR; Pastar I; Kirsner RS; Andreopoulos FM; Musi JP; Tomic-Canic M
Commun Biol; 2021 Jun; 4(1):757. PubMed ID: 34145387
[TBL] [Abstract][Full Text] [Related]
6. Strategy for Treatment of Infected Diabetic Foot Ulcers.
Chang M; Nguyen TT
Acc Chem Res; 2021 Mar; 54(5):1080-1093. PubMed ID: 33596041
[TBL] [Abstract][Full Text] [Related]
7. Peptide RL-QN15 promotes wound healing of diabetic foot ulcers through p38 mitogen-activated protein kinase and smad3/miR-4482-3p/vascular endothelial growth factor B axis.
Sun D; Guo K; Liu N; Li Y; Li Y; Hu Y; Li S; Fu Z; Wang Y; Wu Y; Zhang Y; Li J; Li C; Wang Z; Kang Z; Sun J; Wang Y; Yang X
Burns Trauma; 2023; 11():tkad035. PubMed ID: 38026443
[TBL] [Abstract][Full Text] [Related]
8. Integrative analysis of miRNA and mRNA paired expression profiling of primary fibroblast derived from diabetic foot ulcers reveals multiple impaired cellular functions.
Liang L; Stone RC; Stojadinovic O; Ramirez H; Pastar I; Maione AG; Smith A; Yanez V; Veves A; Kirsner RS; Garlick JA; Tomic-Canic M
Wound Repair Regen; 2016 Nov; 24(6):943-953. PubMed ID: 27607190
[TBL] [Abstract][Full Text] [Related]
9. Translational development of ABCB5
Kerstan A; Dieter K; Niebergall-Roth E; Klingele S; Jünger M; Hasslacher C; Daeschlein G; Stemler L; Meyer-Pannwitt U; Schubert K; Klausmann G; Raab T; Goebeler M; Kraft K; Esterlechner J; Schröder HM; Sadeghi S; Ballikaya S; Gasser M; Waaga-Gasser AM; Murphy GF; Orgill DP; Frank NY; Ganss C; Scharffetter-Kochanek K; Frank MH; Kluth MA
Stem Cell Res Ther; 2022 Sep; 13(1):455. PubMed ID: 36064604
[TBL] [Abstract][Full Text] [Related]
10. Single-cell profiling reveals transcriptomic signatures of vascular endothelial cells in non-healing diabetic foot ulcers.
Lu Y; Liu X; Zhao J; Bie F; Liu Y; Xie J; Wang P; Zhu J; Xiong Y; Qin S; Yang F; Chen L; Xu Y
Front Endocrinol (Lausanne); 2023; 14():1275612. PubMed ID: 38107519
[TBL] [Abstract][Full Text] [Related]
11. Poorly designed research does not help clarify the role of hyperbaric oxygen in the treatment of chronic diabetic foot ulcers.
Mutluoglu M; Uzun G; Bennett M; Germonpré P; Smart D; Mathieu D
Diving Hyperb Med; 2016 Sep; 46(3):133-134. PubMed ID: 27723012
[TBL] [Abstract][Full Text] [Related]
12. miR‑193b exhibits mutual interaction with MYC, and suppresses growth and metastasis of osteosarcoma.
Gao J; Ma S; Yang F; Chen X; Wang W; Zhang J; Li Y; Wang T; Shan L
Oncol Rep; 2020 Jul; 44(1):139-155. PubMed ID: 32377743
[TBL] [Abstract][Full Text] [Related]
13. Circular RNA hsa_circ_0084443 Is Upregulated in Diabetic Foot Ulcer and Modulates Keratinocyte Migration and Proliferation.
Wang A; Toma MA; Ma J; Li D; Vij M; Chu T; Wang J; Li X; Xu Landén N
Adv Wound Care (New Rochelle); 2020 Apr; 9(4):145-160. PubMed ID: 32117579
[No Abstract] [Full Text] [Related]
14. Deregulated immune cell recruitment orchestrated by FOXM1 impairs human diabetic wound healing.
Sawaya AP; Stone RC; Brooks SR; Pastar I; Jozic I; Hasneen K; O'Neill K; Mehdizadeh S; Head CR; Strbo N; Morasso MI; Tomic-Canic M
Nat Commun; 2020 Sep; 11(1):4678. PubMed ID: 32938916
[TBL] [Abstract][Full Text] [Related]
15. Comparative Genomic, MicroRNA, and Tissue Analyses Reveal Subtle Differences between Non-Diabetic and Diabetic Foot Skin.
Ramirez HA; Liang L; Pastar I; Rosa AM; Stojadinovic O; Zwick TG; Kirsner RS; Maione AG; Garlick JA; Tomic-Canic M
PLoS One; 2015; 10(8):e0137133. PubMed ID: 26318001
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological and Genetic Inhibition of Caveolin-1 Promotes Epithelialization and Wound Closure.
Jozic I; Sawaya AP; Pastar I; Head CR; Wong LL; Glinos GD; Wikramanayake TC; Brem H; Kirsner RS; Tomic-Canic M
Mol Ther; 2019 Nov; 27(11):1992-2004. PubMed ID: 31409528
[TBL] [Abstract][Full Text] [Related]
17. Mevastatin promotes healing by targeting caveolin-1 to restore EGFR signaling.
Sawaya AP; Jozic I; Stone RC; Pastar I; Egger AN; Stojadinovic O; Glinos GD; Kirsner RS; Tomic-Canic M
JCI Insight; 2019 Dec; 4(23):. PubMed ID: 31661463
[TBL] [Abstract][Full Text] [Related]
18. Neuropeptides, Inflammation, Biofilms, and diabetic Foot Ulcers.
Yang S; Hu L; Han R; Yang Y
Exp Clin Endocrinol Diabetes; 2022 Jul; 130(7):439-446. PubMed ID: 34225369
[TBL] [Abstract][Full Text] [Related]
19. The role of CXCL8 in chronic nonhealing diabetic foot ulcers and phenotypic changes in fibroblasts: a molecular perspective.
Rai V; Moellmer R; Agrawal DK
Mol Biol Rep; 2022 Feb; 49(2):1565-1572. PubMed ID: 35044539
[TBL] [Abstract][Full Text] [Related]
20. S100A8/A9 is an important host defence mediator in neuropathic foot ulcers in patients with type 2 diabetes mellitus.
Trøstrup H; Holstein P; Christophersen L; Jørgensen B; Karlsmark T; Høiby N; Moser C; Ågren MS
Arch Dermatol Res; 2016 Jul; 308(5):347-55. PubMed ID: 27084691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
